GL1X · GenesisL1 explorer

Research workbench

2-substituted-16-ene-22-thia-1ALPHA,25-dihydroxy-26,27- dimethyl-19-norvitamin D3 analogs: synthesis, biological evaluation and crystal structure

Analyse 2-substituted-16-ene-22-thia-1ALPHA,25-dihydroxy-26,27- dimethyl-19-norvitamin… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZLA
Type
protein
Length
249 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vitamin D3 receptor; Coactivator peptide drip
UniProt
P13053
Ligands
VDB
Pockets
2 · best druggability 0.87

Structure

x-ray diffraction · 2 distinct chains · 66% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVitamin D3 receptorprotein23866% helix, 3% strandP13053
CCoactivator peptide dripprotein1164% helix, 0% strand—

Ligands and binding sites

  • VDB · (1R,2S,3R,5Z,7E)-17-{(1R)-1-[(2-ethyl-2-hydroxybutyl)sulfanyl]ethyl}-2-(2-hydroxyethoxy)-9,10-secoestra-5,7,16-triene-1,3-diol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13220.870.9638VDB
2980.360.7524empty

Interfaces

1 interface between chains.

  • A–C · 577 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 2ZLA · 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs… · the same entry in another collection · chain A against A, TM-score 1.00
  • P13053 · AlphaFold monomer V2.0 prediction for vitamin D3 receptor (P13053) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.